Home > M&A deals 2012 > Telegraph Hill Partners invests in RareCyte, Inc.
Venture · Life Science · August 2012

Telegraph Hill Partners invests in RareCyte, Inc.

On August 21, 2012, Telegraph Hill Partners invested in RareCyte, Inc., a life science company in Washington, United States.

Deal at a glance

AnnouncedAugust 21, 2012 TypeVenture TargetRareCyte, Inc. Buyer Telegraph Hill Partners SectorLife Science LocationWashington, United States ValueNot disclosed

Target company

RareCyte, Inc.
Washington, United States
Life Sciencesector
2012founded
Activestatus
View the company profile →

Buyer

Telegraph Hill Partners
Private equity firm · 40 deals on record
  • 6th transaction in life science
  • 20th transaction in United States
40deals, all time
16in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired RareCyte, Inc.?Telegraph Hill Partners invested in RareCyte, Inc. on August 21, 2012.

What type of deal was it?It was a venture in the life science sector in 2012.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).